SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Alexion Pharmaceuticals, Inc. (ALXN)
An SI Board Since October 1997
Posts SubjectMarks Bans Symbol
824 29 0 ALXN
Emcee:  Larry Liebman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
449Didn't see a PR for this note from Briefing... 15:07 ET Alexion Pharm annouIan@SI-5/18/2004
448One Year Cumulative Results of Alexion Pharmaceuticals' Ongoing Clinical Trikeokalani'nui-4/20/2004
447Alexion Pharmaceuticals Registers $150M Mixed Sec Shelf DOW JONES NEWSWIRES Aprmopgcw-4/14/2004
446An Open-Label, Dose-Finding Study Evaluating the Safety and Platelet Response ofkeokalani'nui-3/19/2004
4458,000-patient aMI pivotal! Whew, doggies! What's the last biologic tested keokalani'nui-3/13/2004
444Ice, I vaguely recall hearing/thinking/reading/imagining that the high risk popkeokalani'nui-3/9/2004
443Oh well, at least it looks like there's a path to Pex being approved as oppoIan@SI-3/9/2004
442So, there are - if I have understood things correctly -good news and there are bIcebrg-3/9/2004
441Alexion Pharmaceuticals Reports Pexelizumab Reduces Inflammation in Acute MyocarIan@SI-3/9/2004
440These guys really know how to run, or should that be "RUIN", a confereIan@SI-3/8/2004
439No idea. Not less than 4k, and thereabouts, I would think.keokalani'nui-3/8/2004
438Any idea how large the referenced new trials will have to be??? ++++++++++++++Ian@SI-3/8/2004
437I think alxn strengthened in a surprisingly non-volatile manner beginning about keokalani'nui-3/3/2004
436PNH effect? Yes, you may very well be right. But what about the webcast? Such aIcebrg-3/3/2004
435I think one of the houses finally commissioned an intelligent study on the prevakeokalani'nui-3/3/2004
434>>Might this be the reason for ALXN's recent performance????>> Icebrg-3/3/2004
433Might this be the reason for ALXN's recent performance???? Alexion PharmaceIan@SI-3/3/2004
432AVANT Starts Phase IIb Study Of TP10 In Women Undergoing Cardiac Surgery UtiliziIcebrg-2/17/2004
431I think it is too encouraging and in some ways simply baffling. First, the $2k-keokalani'nui-2/12/2004
430I think there was a typo in the first part of the report: <i> We apply a Ian@SI-2/12/2004
429Those revenue numbers are whacky not that I'm complaining. Thanks george, ckeokalani'nui-2/11/2004
428WAC part 2: Phase IIb Results Nearly 900-patients undergoing CABG w/CPB (withmopgcw-2/11/2004
427WACHOVIA SECURITIES February 09, 2004 ALXN: Initiating Covemopgcw-2/11/2004
426That's the thing about Oakland. If you live here, it's so damn conveniescaram(o)uche-2/11/2004
425There will be a next time. And payback I'm sure! BTW, A RANT! I'm vekeokalani'nui-2/11/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News